Talk:B-cell maturation antigen
Add topicAppearance
Latest comment: 9 years ago by Rod57 in topic Could mention
| This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
| ||||||||||||||
| The content of ALLO-715 was merged into B-cell maturation antigen on 8 February 2023. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. For the discussion at that location, see its talk page. |
| ALLO-715 was merged into this article. The discussion was closed on 30 May 2022 with a consensus to merge. The original page is now a redirect to this article. Its history now serves to provide attribution for the content in this article, and it must not be deleted as long as this article exists. |
Could mention
[edit]It is an experimental T-cell therapy target - for MM. - Rod57 (talk) 15:41, 25 March 2017 (UTC)
